The Department of Justice faces a pointed question from antitrust commentators: does it have the tools — and the will — to unwind the seed and crop-chemical mergers it cleared during the last consolidation wave?

That is the challenge laid out in a new analysis published by Promarket, the University of Chicago Booth School of Business policy site. The piece, titled "The DOJ Knows What To Do About Those Seed Mergers. Will It Reverse Them?", argues the department already possesses the legal authority to revisit deals that concentrated seed traits, trait licensing and paired herbicide platforms. What remains uncertain, the author contends, is whether prosecutors will actually use it.

For growers and farm-input buyers, the stakes are direct. Seed spending ranks among the largest variable costs per acre for row-crop producers, alongside fertilizer and crop-protection chemistry. When trait providers and chemical platforms combine under one roof, farmers typically face narrower choices among stacked-trait seed brands and tighter bundles between genetics and the herbicides those genetics tolerate. Cooperative agronomists and independent seed dealers have long argued that remedy packages — divestitures and licensing commitments negotiated at closing — did not fully restore the competitive pressure that existed before the deals closed.

The Promarket analysis centers on a structural question that antitrust economists have debated since the mergers closed: behavioral remedies and targeted divestitures, however carefully drafted, leave the underlying market structure intact. Once a reviewing administration changes, enforcement priorities shift, and the commitments that regulators accepted years earlier can look thin against the market power sellers now exercise. The piece's core claim is that DOJ antitrust staff understand this problem and know the remedial playbook — including the rare but established step of seeking to dissolve consummated mergers through litigation.

Reversing a closed deal is legally difficult. Courts require the government to prove the merger substantially lessened competition, and merging parties typically argue that remedies already cured any harm, that markets have changed since closing, and that unwinding integrated operations would impose costs of its own. Those defenses matter in agriculture, where trait platforms, breeding pipelines and data subscriptions are now deeply integrated across product lines. A divestiture ordered years after integration could force a buyer to reconstruct seed development programs that no longer exist as stand-alone businesses.

The timing of the piece matters for the farm policy calendar. Antitrust scrutiny of agricultural input markets has drawn renewed congressional attention in recent sessions, with lawmakers from both parties questioning concentration in seeds, crop chemicals and meatpacking. Farmers testifying at those hearings have repeatedly tied input pricing power to squeezed operating margins, even in years with strong commodity prices. A DOJ decision to revisit approved seed mergers would mark one of the most aggressive uses of consummated-merger litigation in modern antitrust practice, and it would test whether the department can rebuild competition in a market that has already consolidated.

Whether that happens, the Promarket author concludes, depends less on legal capability than on enforcement appetite — a question the piece leaves squarely with the department's leadership.